A Study of Insulin Degludec/Insulin Aspart Biosimilar (22011) Compared With Insulin Degludec/Insulin Aspart(Ryzodeg) in Participants With Type 2 Diabetes in China
Clinical trial NCT05802862 · COMPLETED
Trial details
- NCT number
- NCT05802862
- Sponsor
- Sunshine Lake Pharma Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-06
- Primary completion
- 2024-08-16
- Enrollment
- 414
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.